Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: Preliminary results

Medical Science Monitor

Volumn 17, Issue 11, 2011, Pages 13-18

  Stepień, Mariusz ^a   Rosniak Bak, Kinga ^a   Paradowski, Marek ^a   Misztal, Malgorzata ^b   Kujawski, Krzysztof ^a   Banach, Maciej ^a   Rysz, Jacek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Adipokines; Ghrelin; Insulin resistance; Obese patients; Waist circumference

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GHRELIN; GLUCOSE; INSULIN; LEPTIN; RESISTIN;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CORRELATIONAL STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; OBESITY; OUTPATIENT; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 80355149272     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/msm.882030     Document Type: Article

References (44)

1. Esteve E, Ricard W, Fernández-Real JM: Adipocytokines and Insulin Resistance. The possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes Care, 2009; 32: S362-67
2. Kusminski CM, McTernan P, Kumar S: Role of resistin in obesity, insulin resistance and Type II diabetes. Clin Sci, 2005; 109: 243-56
3. Duncan BB, Schmidt MI, Pankow JS et al: Adiponectin and the development of type 2 diabetse: the Atherosclerosis Risk in Communities Study. Diabetes, 2004; 53: 2473-78
4. Mohamed MH, Gad GI, Ibrahim HY et al: Cord blood resistin and ad-iponectin in term newborns of diabetic mothers. Arch Med Sci, 2010; 6: 558-66
5. Grycewicz J, Scibor Z, Cwikla JB et al: Recurrent hypoglycaemia in a type 2 diabetes patient - diagnostic diffculties. Arch Med Sci, 2010; 6: 126-29
6. Tatli E, Aktoz M, Altun A: Do plasma leptin levels predict diastolic dysfunction in patients with hypertension? Arch Med Sci, 2009; 5: 342-46
7. Lu J-Y, Huang K-Ch, Chang L-C et al: Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond. J Biomed Sci, 2008; 15: 565-76
8. Fawaz L, Elwan AE, Kamel YH et al: Value of C-reactive protein and IL-6 measurements in type 1 diabetes mellitus. Arch Med Sci, 2009; 5: 383-90
9. Gordon L, Ragoobirsingh D, Morrison E et al: Dyslipidaemia in hypertensive obese type 2 diabetic patients in Jamaica. Arch Med Sci, 2010; 6: 701-8
10. Fasshauer M, Paschke R: Regulation of adipocytokines and insulin resistance. Diabetologia, 2003; 46: 1594-603
11. Taylor VH, MacQueen GM: The Role of Adipokines in Understanding the Associations between Obesity and Depression. J Obes, 2010; 2010. pii: 748048. Epub 2010 Jul 28
12. Lee JH, Chan JL, Yiannakouris N et al: Circulating Resistin Levels Are Not Associated with Obesity or Insulin Resistance in Humans and Are Not Regulated by fasting or Leptin Administration: Cross-Sectional and Interventional Studies in Normal, Insulin-Resistant, and Diabetic Subjects. J Clin Endocrinol Metab, 2003; 88: 4848-56
13. Ukkola O: Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander? Eur J Endocrinol, 2002; 147: 571-74
14. Lee S, Bacha F, Gungor N, Arsianian SA: Waist circumference in an independent predictor of insulin resistance in black and white youths. J Pediatr, 2006; 148: 188-94
15. Nilsson G, Hedberg P, Jonason T et al: Waist circumference alone predicts insulin resistance as good as the metabolic syndrome in elderly women. Eur J Intern Med, 2008; 19: 520-26
16. Tabata S, Yoshimitsu S, Hamachi T et al: Waist circumference and insulin resistance: a cross-sectional study of Japanese men. BMC Endocrine Disorders, 2009; 9: 1-7
17. Lee S, Bacha F, Gungor N, Arsianian SA: Waist circumference is an independent predictor of insulin resistance in black and white youths. J Pediatr, 2006; 148: 188-94
18. Wahrenberg H, Hertel K, Leijonhufvud B-M et al: Use of waist circumference to predict insulin resistance: retrospective study. BMJ, 2005; 330: 1363-64
19. Delavari A, Kelishadi R, Forouzanfar MH et al: The frst cut-off points for generalized and abdominal obesity in predicting lipid disorders in a nationally representative population in the Middle East: The National Survey of Risk Factors for Non-Communicable Diseases of Iran. Arch Med Sci, 2009; 5: 542-49
20. Ravipati G, Aronow WS, Kumbar S et al: Patients with diabetes mellitus with ischemic stroke have a higher hemoglobin A1c level and a higher serum low-density lipoprotein cholesterol level than diabetics without ischemic stroke. Arch Med Sci, 2009; 5: 391-93
21. Park K, Lee D-H, Erickson DJ et al: Association of Long-Term Change in Waist Circumference With Insulin Resistance. Obesity, 2010; 18: 370-76
22. Fasshauer M, Paschke R: Regulation of adipocytokines and insulin resistance. Diabetologia, 2003; 46: 1594-603
23. Hivert M-F, Sullivan LM, Fox CS et al: Associations of Adiponectin, Resistin, and Tumor Necrosis Factor-a with Insulin Resistance. J Clin Endocrinol Metab, 2008; 93: 3165-72
24. Rabe K, Lehrke M, Parhofer KG, Broedl UC: Adipokines and Insulin Resistance. Mol Med, 2008; 14: 741-51
25. Meier U, Gressner AM: Endocrine Regulation of Energy Metabolism: Review of Pathobiochemical and Clinical Chemical Aspects of Leptin, Ghrelin, Adiponectin, and Resistin. Clin Chem, 2004; 50: 1511-25
26. Kostulski A, Pawelczyk T, Rabe-Jablonska J: The risk of signifcant body weight gain and abdominal obesity during short-term treatment with olanzapine. Arch Med Sci, 2009; 5: 259-66
27. Banach M, Goch JH, Ugurlucan M et al: Obesity and postoperative atri-al fbrillation. Is there no connection? Comment on: Wanahita et al: "atrial fbrillation and obesity - results of a meta-analysis". Am Heart J, 2008; 156: e5
28. Malyszko J, Zbroch E, Malyszko J et al: The cardio-renal-anaemia syndrome predicts survival in peritoneally dialyzed patients. Arch Med Sci, 2010; 6: 539-44
29. Goch A, Misiewicz P, Rysz J, Banach M: The clinical manifestation of myocardial infarction in elderly patients. Clin Cardiol, 2009; 32: E46-51
30. Symonides B, Jedrusik P, Artyszuk L et al: Different diagnostic criteria signifcantly affect the rates of hypertension in 18-year-old high school students. Arch Med Sci, 2010; 6: 689-94
31. Singh M, Bedi US, Singh PP et al: Leptin and the clinical cardiovascular risk. Int J Cardiol, 2010; 140: 266-71
32. Saad MF, Rewers M, Selby J et al: Insulin Resistance and Hypertension. The Insulin Resistance Atherosclerosis Study. Hypertension, 2004; 43: 1324-31
33. Kim JY, Shin HW, Jeong IK et al: The relationship of adiponectin, leptin and ghrelin to insulin resistance and cardiovascular risk factors in human obesity. Korean J Med, 2005; 69: 631-41
34. Staiger H, Tschritter O, Machann J: Relationship of Serum Adiponectin and Leptin Concentrations with Body Fat Distribution in Humans. Obesity Res, 2003; 11: 368-72
35. Park K-G, Park KS, Kim Mi-J et al: Relationship between serum adipo-nectin and lepton concentrations and body fat distribution. Diab Res Clin Pract, 2004; 63: 135-42
36. Vendrell J, Broch M, Vilarrasa N et al: Resistin, Ghrelin, Leptin, and Proinfammatory Cytokines: Relationships in Obesity. Obesity Res, 2004; 12: 962-71
37. Pöykko SM, Kellokoski E, Horkko S et al: Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes, 2003; 52: 2546-53.
38. Öner-Iyidogan Y, Koçak H, Gürdol F et al. Circulating ghrelin levels in obese women: a possible association with hypertension. Scand J Clin Lab Invest, 2007; 67: 568-76
39. Dytfeld J, Pupek-Musialik D: Ghrelin and its relationship with insulin resistance in obese hypertensive patients. Przegl Kardiodiabetol, 2007; 2: 27-34
40. Cummings DE, Overduin J: Gastrointestinal regulation of food intake. J Clin Invest, 2007; 117: 13-23
41. Duncan BB, Schmidt MI, Pankow JS et al: Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes, 2004; 53: 2473-78
42. Snijder MB, Heine RJ, Seidell JC et al: Associations of adiponectin levels with incident impaired glucose metabolism ant type 2 diabetes in older men and women: the Hoorn study. Diabetes Care, 2006; 29: 2498-508
43. Araszkiewicz A, Zozulinska-Ziolkiewicz D, Wierusz-Wysocka B: Insulinoma in a patient with long lasting type 2 diabetes. Arch Med Sci, 2009; 5: 486-88
44. Barylski M, Kowalczyk E, Banach M et al: Plasma total antioxidant activity in comparison with plasma NO and VEGF levels in patients with metabolic syndrome. Angiology, 2009; 60: 87-92